| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/09/2003 | EP1325956A1 Plant lesion formation suppressing gene, sp17 and use theriof |
| 07/09/2003 | EP1325931A1 Inhibitors of human neutrophil elastase |
| 07/09/2003 | EP1325930A1 Mammal prolactin variants |
| 07/09/2003 | EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/09/2003 | EP1325754A1 Wound dressing materials comprising collagen and oxidized cellulose |
| 07/09/2003 | EP1325678A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same |
| 07/09/2003 | EP1325336A2 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/09/2003 | EP1325150A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain |
| 07/09/2003 | EP1325149A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 07/09/2003 | EP1325145A1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 07/09/2003 | EP1325140A2 A nitrate-responsive plant root specific transcriptional factor |
| 07/09/2003 | EP1325139A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 07/09/2003 | EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 07/09/2003 | EP1325132A2 Human ion channel protein and polynucleotides encoding the same |
| 07/09/2003 | EP1325131A2 A human-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 07/09/2003 | EP1325130A2 Nogo receptor homologs |
| 07/09/2003 | EP1325129A2 Identification of a new cytotoxic activity from the ink of aplysia punctata |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325126A2 Human ion-exchanger proteins and polynucleotides encoding the same |
| 07/09/2003 | EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors |
| 07/09/2003 | EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 07/09/2003 | EP1325123A1 Inhibition of stenosis or restenosis by p-selectin antagonists |
| 07/09/2003 | EP1325120A2 Novel nucleic acids and polypeptides |
| 07/09/2003 | EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 07/09/2003 | EP1325115A2 Cytokine receptor zcytor17 |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325029A2 Secreted proteins and their uses |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 07/09/2003 | EP1325021A1 12 human secreted proteins |
| 07/09/2003 | EP1325020A1 21 human secreted proteins |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324777A1 Regioselective liquid phase pegylation |
| 07/09/2003 | EP1324770A2 Non-replicative particulate vaccine delivery system and methods of making and using same |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324765A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 07/09/2003 | EP1324763A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 07/09/2003 | EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid |
| 07/09/2003 | EP1112081A4 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
| 07/09/2003 | EP1080109B1 Method for purification of borrelia lipoprotein ospa |
| 07/09/2003 | EP1000177A4 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 07/09/2003 | EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 07/09/2003 | EP0920443B1 Activated peptides and conjugates |
| 07/09/2003 | EP0914340B1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
| 07/09/2003 | EP0900380B1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/09/2003 | EP0894004B1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 07/09/2003 | EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein |
| 07/09/2003 | EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes |
| 07/09/2003 | EP0717631B1 Immunomodulating compositions from bile |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | EP0511308B2 Chimeric immunoglobulin for cd4 receptors |
| 07/09/2003 | CN1429275A Matrix reactor and method for producing products in said reactor |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429271A Corynebacterium glutamicum strain with enhanced secretion activity |
| 07/09/2003 | CN1429270A Synthetic gagpol genes and their use |
| 07/09/2003 | CN1429269A Receptors for hypersensitive response elicitors and uses thereof |
| 07/09/2003 | CN1429235A Full-length infectious CDNA clones of tick borne flavivirus |
| 07/09/2003 | CN1429116A Pharmaceutical composition |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428425A Contruction and purification process of recombinant human soluble necrohormone 2 ligand |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1428351A Wheat 1B†ù14 gene, its coded protein and its promotor |
| 07/09/2003 | CN1428348A Clone, expression and biological activity of stingray caudal spine cyclophilin A gene |
| 07/09/2003 | CN1428347A Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/09/2003 | CN1428346A Nucleic acid, probe containing said nucleic acid and screening method using said probe |
| 07/09/2003 | CN1114106C Peptide marked with metal chelate and preparing method thereof |
| 07/09/2003 | CN1113964C High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus |
| 07/09/2003 | CN1113962C Stress resistant plant in which cell death suppressing gene is introduced and method for producing same |
| 07/09/2003 | CN1113961C Gene expression regulatory NDA, expression cassette and expression carrier |
| 07/09/2003 | CN1113896C Method for preparing epidermal growth factor using marine and discard material |
| 07/09/2003 | CN1113656C Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 07/08/2003 | US6590142 Isolated nucleic acid of given sequence; confers insect resistance |
| 07/08/2003 | US6590140 Transgenic plant which expresses a polypeptide comprising given amino acid sequence; iron uptake; can be used to remove pollutants from soil or as nutritional supplements to treat iron- or zinc-deficiency |
| 07/08/2003 | US6590090 Isolated DNA comprising nucleotide sequence coding for a protein of given amino acid sequence; useful as prophylactic or therapeutic agents for cancer, viral/bacterial infections, hepatitis, nephritis, bone disease, atherosclerosis or pain |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590088 CD33-like protein |
| 07/08/2003 | US6590087 Isolated nucleic acid sequence encoding the protein; can use in treatment of tuberculosis and leprosy; can use in drug screening and antibiotic development |
| 07/08/2003 | US6590086 Mutants of the Rb and p53 genes and uses thereof |
| 07/08/2003 | US6590081 Crystalline teriparatide |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6590075 Secreted protein HODAZ50 |
| 07/08/2003 | US6590074 Prosaposin receptor |
| 07/08/2003 | US6590072 Method for extractive refolding of scrambled single-chain polypeptides |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589940 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/08/2003 | US6589936 Therapeutically effective amounts of recombinant troponin C, I or T subunits for the treatment of diseases or disorders involving abnormal angiogenesis. |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589933 Chemokine binding protein 5(type-2 CBP) encoded by poxviruses and having amino acid sequence homology with the Shope fibroma virus T1 family of proteins against disease syndromes associated with acute or chronic dysregulated inflammatory |
| 07/08/2003 | US6589787 T-type calcium channel variants; compositions thereof; and uses |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589775 Use in producing clavulanic acid from a transformed, non-clavulanate-producing streptomyces as well as enhanced production from a clavulanate-producing streptomyces transformed using an isolated DNA recombinant vector |
| 07/08/2003 | US6589768 Deoxyribonucleotide deletion (3'end) in reverse transcriptase (RT) gene results in RT gene with DNA polymerase activity and no RNase H activity; fusion proteins; vectors; kits; use to synthesize cDNA from mRNA without RNase H degrading the mRNA |
| 07/08/2003 | US6589764 IL-18 receptor fusion proteins |
| 07/08/2003 | US6589763 Retroviral hybrid vectors pseudotyped with LCMV |
| 07/08/2003 | US6589755 Assay for quantifying arthritic conditions |